Incidence and risk of fatigue in cancer patients treated with MET inhibitors: A systematic review and meta-analysis

AbstractBackground:The N-methyl-N′-nitroso-guanidine human osteosarcoma transforming gene (MET) inhibitors show a surprising survival benefit in the treatment of numerous tumors especially in MET-high tumor. Besides their impressive efficacy, fatigue reduced by MET inhibitors is still the safety iss